Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    PSMA6
Show Display Options
Rank Status Study
1 Active, not recruiting Vaccine Therapy in Treating Patients With Kidney Cancer
Condition: Kidney Cancer
Interventions: Biological: human prostate-specific membrane antigen plasmid DNA vaccine;   Biological: mouse prostate-specific membrane antigen plasmid DNA vaccine
2 Completed Efficacy of Portion Size Measurement Aids
Conditions: Nutrition Assessment;   Obesity
Intervention: Behavioral: Portion Size Measurement Aids (PSMAs)
3 Active, not recruiting A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: 99mTc MIP 1404
4 Recruiting 18F-DCFBC PET/CT in Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention: Drug: 18F DCFBC
5 Recruiting Efficacy, Safety and CNS Exposure of G-202 in Patients With Recurrent or Progressive Glioblastoma
Conditions: Recurrent Glioblastoma;   Progressive Glioblastoma
Intervention: Drug: G-202
6 Active, not recruiting Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection
Condition: Prostate Cancer
Intervention: Drug: 99mTc-MIP-1404

Indicates status has not been verified in more than two years